Maven Securities LTD

SEC CIK: 0001633046
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Maven Securities LTD, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of RARE by Maven Securities LTD, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−20,000−100.0%	Sold out	Holders
Q2 2024	20,000	$822.0K	0.1%	+10,000+100.0%	Added	Holders
Q1 2024	10,000	$466.9K	<0.1%	+10,000	New	Holders